Article
DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas
21 Sept 2013
Abstract excerpt
PURPOSE: Oncolytic viruses (OV) based on herpes simplex virus type 1 (HSV1) are being used in clinical trials for a variety of cancers. The OV, rQNestin34.5, uses a nestin promoter/enhancer to selectively drive robust viral replication in malignant glioma cells. We have discovered that this promoter becomes extensively methylated in infected glioma cells, reducing OV efficacy. EXPERIMENTAL DESIGN: We used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
